US Experience With Infliximab Biosimilars Suggests Need for More Development Incentives.

Saved in:
Bibliographic Details
Title: US Experience With Infliximab Biosimilars Suggests Need for More Development Incentives.
Authors: Evans, Jeff
Source: Pediatric News. Aug2024, p1-2. 2p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 179579620
AccessLevel: 2
PubType: News
PubTypeId: newspaperArticle
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: US Experience With Infliximab Biosimilars Suggests Need for More Development Incentives.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Evans%2C+Jeff%22">Evans, Jeff</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Pediatric+News%22">Pediatric News</searchLink>. Aug2024, p1-2. 2p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=179579620
RecordInfo BibRecord:
  BibEntity:
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 2
        StartPage: 1
    Titles:
      – TitleFull: US Experience With Infliximab Biosimilars Suggests Need for More Development Incentives.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Evans, Jeff
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: Aug2024
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 0031398X
          Titles:
            – TitleFull: Pediatric News
              Type: main
ResultId 1